CymaBay Therapeutic (CBAY) PT Raised to $9 at Citi on Increased Probability of Seladelpar for PBC Approval
Tweet Send to a Friend
(Updated - August 25, 2020 7:07 AM EDT)Citi analyst Joel Beatty raised the price target on CymaBay Therapeutic (NASDAQ: CBAY) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
